PAIS — Project Alfa Intellective Solutions
EN
← All programmes

Health & care

AZHYU

In development
Development signal38%

Indicative planning signal — not funding collected, product availability or release readiness.

A person-centred health and care platform programme. Its product and regulatory path are being developed; no clinical service or medical outcome is offered here.

AZHYU is in development and does not offer diagnosis, treatment or clinical services through this website.

About this visual

PAIS brand artwork · product-specific visuals are being prepared.

WHO IT IS FOR

Built around
people & purpose.

People and organisations interested in person-centred care experiences.

THE IDEA

A person-centred direction

AZHYU is a health and care platform programme whose development previously used the working name AHOMA. Its central idea is to organise the experience around the person, rather than starting from the boundaries between services. The selected name reflects this direction: a broad health and care ecosystem with the individual at its centre.

THE EXPERIENCE

Connecting experiences thoughtfully

The programme explores how people and organisations might navigate a more connected care experience. Product design, privacy and appropriate clinical responsibility are part of that work. EMEDEME is a separate programme with its own medication-related scope; possible interoperability is being developed without treating the two products as interchangeable or assuming that a live connection already exists.

WHAT COMES NEXT

A focused non-clinical next step

The proposed next milestone is a non-clinical demonstration using suitable example data. It would provide a way to examine the experience and gather feedback before expanding access. Wider services, integrations and any clinical use would need their own validation and approvals. The current profile presents the product direction, not a medical service or an outcome promise.

PROPOSED NEXT STEP

A meaningful milestone.

Proposed: validate a non-clinical experience with appropriate privacy and safety review.

01

Non-clinical product development updates

02

A design feedback session using demonstration data

03

A future non-clinical evaluation, only within its approved scope

These are proposed directions, not an active offer. Reward scope, delivery, licence terms and refunds must be published before any reward campaign opens.

Express interest

VOLUNTARY PROJECT SUPPORT / USD

Support AZHYU.

Contribute by bank transfer, with a reference dedicated to this project.

Make the transfer from your own bank. This website does not initiate transfers or confirm receipt.

Voluntary support does not purchase a product, reward, licence or equity. Proposed rewards elsewhere on this page are separate and are not included with a donation.

Questions before contributing? ↗
Currency
USD — U.S. dollars
Beneficiary
LLC project alfa
Bank
JSC TBC Bank
SWIFT / BIC
TBCBGE22
Beneficiary IBAN
GE59TB7905636120100008
Transfer reference / payment description
AZHYU donation

Intermediary bank details

The TBC USD instructions list the following intermediaries. Follow your sending bank’s routing instructions; this page does not select an intermediary.

  • Citibank N.A. — New York, USA
    SWIFT: CITIUS33
  • JPMorgan Chase Bank National Association — New York, USA
    SWIFT: CHASUS33